NCT07522645
Adherence to Dyslipidemia Therapy: Harnessing Evidence From Randomized Evaluations in AtheroSclerotic CardioVascular Disease
Active, Not Recruiting
NAAges 18+InterventionalKaiser PermanenteInvestigator-initiated
~22,000 participants
Updated 2026-07-06 on ClinicalTrials.gov
What's tested:SMS (Initial Outreach)Secure Portal Message (Initial Outreach)Non-secure Email (Initial Outreach)SMS (Follow-up for Non-responders)Secure Portal Message (Follow-up for Non-responders)Non-secure Email (Follow-up for Non-responders)
At a glance
Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Statin refill after message delivery
Measured over Within 14 days after each stage of message delivery
Conditions
Where it's being run
1 sites across 1 statesCalifornia1
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
What this trial measures
- Statin refill after message deliveryWithin 14 days after each stage of message delivery
Proportion of participants who refill a statin prescription following message delivery (first-stage intervention) or, among non-responders, following second-stage messaging. Refill status will be determined using pharmacy dispensing records.